Year archive

NeuroThera Labs Inc. — 2023 filings

All 18 regulatory filings released by NeuroThera Labs Inc. (NTLX) in 2023, sourced directly from the official regulator.

18 Filings

2023 Period

2023 filings (18)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CFO (E).pdf Capital/Financing Update	2023-12-18	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-12-18	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-12-18	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-12-16	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-12-16	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-12-15	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-12-15	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-12-15	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-12-15	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-09-29	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-09-29	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-09-29	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-09-29	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2023-05-31	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2023-05-31	English
Annual MD&A - English.pdf Management Reports	2023-05-31	English
Audited annual financial statements – English.pdf Annual Report	2023-05-31	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2023-05-31	English